Clinical course and outcome of an outpatient clinic population with myasthenia gravis and COVID‐19

Introduction/Aims Coronavirus disease‐2019 (COVID‐19) may have a more severe course in patients with myasthenia gravis (MG). We aimed to assess severity of the infection and factors contributing to its severity in a group of MG patients, most of whom were not hospitalized. Methods One hundred forty...

Ausführliche Beschreibung